DekaBank Deutsche Girozentrale - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 175 filers reported holding CARA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.0%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$246,000
+7.4%
16,2000.0%0.00%0.0%
Q2 2021$229,000
-30.4%
16,2000.0%0.00%0.0%
Q1 2021$329,000
+34.8%
16,2000.0%0.00%0.0%
Q4 2020$244,000
+23.9%
16,2000.0%0.00%0.0%
Q3 2020$197,000
-74.6%
16,200
-65.9%
0.00%
-80.0%
Q4 2019$776,000
-22.2%
47,500
-11.2%
0.01%
-16.7%
Q3 2019$997,000
-20.7%
53,500
-10.1%
0.01%0.0%
Q2 2019$1,258,000
+365.9%
59,500
+340.7%
0.01%
+200.0%
Q1 2019$270,000
+88.8%
13,500
+22.7%
0.00%
+100.0%
Q4 2018$143,000
-47.0%
11,000
-18.5%
0.00%
-50.0%
Q3 2018$270,000
+3.8%
13,5000.0%0.00%0.0%
Q2 2018$260,000
+58.5%
13,5000.0%0.00%
+100.0%
Q1 2018$164,000
-24.8%
13,500
-2.2%
0.00%
-50.0%
Q4 2015$218,000
+11.2%
13,800
+0.7%
0.00%0.0%
Q3 2015$196,000
+43.1%
13,700
+21.2%
0.00%0.0%
Q2 2015$137,000
+29.2%
11,300
+7.6%
0.00%
+100.0%
Q1 2015$106,00010,5000.00%
Other shareholders
CARA THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Ridgeback Capital Investments L.P. 622,140$10,489,00045.13%
RHO CAPITAL PARTNERS INC 2,668,057$44,983,00015.47%
Opaleye Management Inc. 427,000$7,199,0003.01%
DAFNA Capital Management LLC 169,331$2,855,0002.54%
Private Capital Advisors, Inc. 246,850$4,162,0001.80%
WALL STREET ASSOCIATES 192,300$3,242,0000.91%
SECTORAL ASSET MANAGEMENT INC 1,212,578$20,444,0000.87%
Virtus ETF Advisers LLC 17,299$292,0000.80%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 618,140$10,422,0000.58%
SPHERA FUNDS MANAGEMENT LTD. 197,820$3,335,0000.49%
View complete list of CARA THERAPEUTICS INC shareholders